| Trial ID: | L4168 |
| Source ID: | NCT01230034
|
| Associated Drug: |
Ramipril
|
| Title: |
Antiproteinuric Effect of Imidapril Versus Ramipril in Type 2 Diabetic and Hypertensive Patients With Microalbuminuria
|
| Acronym: |
|
| Status: |
UNKNOWN
|
| Study Results: |
NO
|
| Results: |
|
| Conditions: |
Hypertension|Type 2 Diabetes Mellitus|Microalbuminuria
|
| Interventions: |
DRUG: Ramipril|DRUG: Imidapril
|
| Outcome Measures: |
Primary: Size of the reduction of urinary albumin in 24 hours to the various controls, After 12 weeks from the beginning | Secondary: 1. Size of the reduction of mean 24-hour average daytime and nighttime average. 2. Size of the reduction of central blood pressure. 3. Magnitude of changes in plasma concentrations of angiotensin II, bradykinin and BNP after 24 weeks of treatment., After 12 weeks from the beginning
|
| Sponsor/Collaborators: |
Sponsor: University of Pavia
|
| Gender: |
ALL
|
| Age: |
ADULT, OLDER_ADULT
|
| Phases: |
PHASE3
|
| Enrollment: |
206
|
| Study Type: |
INTERVENTIONAL
|
| Study Designs: |
Allocation: RANDOMIZED|Intervention Model: PARALLEL|Masking: NONE|Primary Purpose: TREATMENT
|
| Start Date: |
2010-10
|
| Completion Date: |
2011-07
|
| Results First Posted: |
|
| Last Update Posted: |
2010-10-28
|
| Locations: |
University of Pavia, Pavia, 27100, Italy
|
| URL: |
https://clinicaltrials.gov/show/NCT01230034
|
